FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2314851328> ?p ?o ?g. }

• W2314851328 endingPage "658" @default.
• W2314851328 startingPage "654" @default.
• W2314851328 abstract "Bladder cancer is the most common malignant tumor of the urinary tract. Novel treatment approaches are essential because of the failure of current treatment options to cure a high percentage of patients. Telomerase, a ribonucleoprotein, is detected in almost all bladder cancer, but not in normal bladder tissues. Therefore, telomerase is expected to be a very promising candidate for targeted therapy of bladder cancer. In this study, we synthesized a 19-mer antisense oligonucleotide against the RNA component of human telomerase (hTR) linked to a 2–5A molecule (2–5A-anti-hTR) and investigated its antitumor effect against bladder cancer cells. The 2–5A antisense strategy relies on the recruitment and activation of RNase L at the site of targeted RNA sequence. Here we demonstrate that treatment with 2–5A-anti-hTR reduced the viability of seven bladder cancer cell lines (UM-UC-2, UM-UC-3, UM-UC-6, UM-UC-9, UM-UC-14, RT4 and T24) expressing telomerase activity to 21–55% within 4 days. The cytotoxicity was mainly due to induction of caspase-dependent apoptosis. In contrast, normal fibroblast WI38 cells lacking telomerase activity were resistant to the treatment. Furthermore, treatment of subcutaneous UM-UC-2 tumors in nude mice with 2–5A-anti-hTR significantly suppressed the tumor growth through induction of apoptosis (P < 0.001). These findings may offer a strong support to the feasibility of the 2–5A-anti-hTR treatment for human bladder cancer." @default.
• W2314851328 created "2016-06-24" @default.
• W2314851328 creator A5007764464 @default.
• W2314851328 creator A5035938912 @default.
• W2314851328 creator A5036467815 @default.
• W2314851328 creator A5061032146 @default.
• W2314851328 date "2001-04-01" @default.
• W2314851328 modified "2023-10-15" @default.
• W2314851328 title "Treatment of bladder cancer cells in vitro and in vivo with 2–5A antisense telomerase RNA" @default.
• W2314851328 cites W1496772673 @default.
• W2314851328 cites W1545398558 @default.
• W2314851328 cites W1775874584 @default.
• W2314851328 cites W1964228845 @default.
• W2314851328 cites W1978289203 @default.
• W2314851328 cites W1996593524 @default.
• W2314851328 cites W2000971601 @default.
• W2314851328 cites W2007613355 @default.
• W2314851328 cites W2007625854 @default.
• W2314851328 cites W2015686762 @default.
• W2314851328 cites W2018089879 @default.
• W2314851328 cites W2026856852 @default.
• W2314851328 cites W2035499819 @default.
• W2314851328 cites W2046651431 @default.
• W2314851328 cites W2060236675 @default.
• W2314851328 cites W2064208421 @default.
• W2314851328 cites W2064400673 @default.
• W2314851328 cites W2068776651 @default.
• W2314851328 cites W2079378073 @default.
• W2314851328 cites W2087004183 @default.
• W2314851328 cites W2108967610 @default.
• W2314851328 cites W2115346781 @default.
• W2314851328 cites W2122994357 @default.
• W2314851328 cites W2123111989 @default.
• W2314851328 cites W2139443220 @default.
• W2314851328 cites W2143318037 @default.
• W2314851328 cites W2158908587 @default.
• W2314851328 cites W2315523562 @default.
• W2314851328 cites W2397494303 @default.
• W2314851328 cites W2417467146 @default.
• W2314851328 doi "https://doi.org/10.1038/sj.gt.3301449" @default.
• W2314851328 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11320413" @default.
• W2314851328 hasPublicationYear "2001" @default.
• W2314851328 type Work @default.
• W2314851328 sameAs 2314851328 @default.
• W2314851328 citedByCount "49" @default.
• W2314851328 countsByYear W23148513282012 @default.
• W2314851328 countsByYear W23148513282014 @default.
• W2314851328 countsByYear W23148513282021 @default.
• W2314851328 countsByYear W23148513282022 @default.
• W2314851328 crossrefType "journal-article" @default.
• W2314851328 hasAuthorship W2314851328A5007764464 @default.
• W2314851328 hasAuthorship W2314851328A5035938912 @default.
• W2314851328 hasAuthorship W2314851328A5036467815 @default.
• W2314851328 hasAuthorship W2314851328A5061032146 @default.
• W2314851328 hasBestOaLocation W23148513281 @default.
• W2314851328 hasConcept C104317684 @default.
• W2314851328 hasConcept C10879258 @default.
• W2314851328 hasConcept C121608353 @default.
• W2314851328 hasConcept C125593758 @default.
• W2314851328 hasConcept C153911025 @default.
• W2314851328 hasConcept C190283241 @default.
• W2314851328 hasConcept C202416437 @default.
• W2314851328 hasConcept C2780352672 @default.
• W2314851328 hasConcept C502942594 @default.
• W2314851328 hasConcept C54355233 @default.
• W2314851328 hasConcept C55493867 @default.
• W2314851328 hasConcept C67705224 @default.
• W2314851328 hasConcept C75934600 @default.
• W2314851328 hasConcept C86803240 @default.
• W2314851328 hasConcept C94581717 @default.
• W2314851328 hasConcept C96232424 @default.
• W2314851328 hasConceptScore W2314851328C104317684 @default.
• W2314851328 hasConceptScore W2314851328C10879258 @default.
• W2314851328 hasConceptScore W2314851328C121608353 @default.
• W2314851328 hasConceptScore W2314851328C125593758 @default.
• W2314851328 hasConceptScore W2314851328C153911025 @default.
• W2314851328 hasConceptScore W2314851328C190283241 @default.
• W2314851328 hasConceptScore W2314851328C202416437 @default.
• W2314851328 hasConceptScore W2314851328C2780352672 @default.
• W2314851328 hasConceptScore W2314851328C502942594 @default.
• W2314851328 hasConceptScore W2314851328C54355233 @default.
• W2314851328 hasConceptScore W2314851328C55493867 @default.
• W2314851328 hasConceptScore W2314851328C67705224 @default.
• W2314851328 hasConceptScore W2314851328C75934600 @default.
• W2314851328 hasConceptScore W2314851328C86803240 @default.
• W2314851328 hasConceptScore W2314851328C94581717 @default.
• W2314851328 hasConceptScore W2314851328C96232424 @default.
• W2314851328 hasIssue "8" @default.
• W2314851328 hasLocation W23148513281 @default.
• W2314851328 hasLocation W23148513282 @default.
• W2314851328 hasOpenAccess W2314851328 @default.
• W2314851328 hasPrimaryLocation W23148513281 @default.
• W2314851328 hasRelatedWork W1549402393 @default.
• W2314851328 hasRelatedWork W2044473828 @default.
• W2314851328 hasRelatedWork W2102536676 @default.
• W2314851328 hasRelatedWork W2114551234 @default.
• W2314851328 hasRelatedWork W2121324028 @default.
• W2314851328 hasRelatedWork W2141515497 @default.

• next